Conclusively, even though the part of the CX3CL1/CX3CR1 axis in the transition of endothelial to mesenchymal is left a mystery, this data proposes that anti‐CX3CL1mAb treatment could be convenient for sheltering against vascular injury during SSc.11 The gene discussed is CX3CR1; the disease is systemic sclerosis.